A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to ...

Trump’s new COVID-19 website features five arguments supporting the lab. Among them was the explanation that Wuhan – the Chinese city where the virus first began spreading – is home to a ...

Current management of HZ with antiviral drugs and analgesics produces reasonable results in younger patients, in whom the disease is usually milder, and is effective against acute pain and skin rash.

The incubation period of SARS-CoV-2 — the virus that causes COVID-19 — varies from person to person. Once it replicates in your cells and reaches higher numbers, you may feel symptoms.

A doctor may examine the rash closely and swab the area to test for MRSA. If they confirm MRSA, treatment may include: Topical antibiotics: Such as mupirocin.

A new COVID-19 variant, informally called 'Nimbus,' is spreading, characterized by a severe sore throat described as feeling like razor blades. While ...

CLEVELAND, Ohio (WOIO) -The World Health Organization is tracking the newest COVID-19 variant which has been given the painful nickname of razor blade throat. As the name suggests, the Nimbus ...

What to know about new COVID variant NB.1.8.1 causing 'razor blade throat' As of the week ending June 7, NB.1.8.1 is the second most dominant variant in the U.S., accounting for an estimated 37% ...

In a webpage dated Jan. 7, 2025, the CDC advises that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine.

A new Covid-19 variant called NB.1.8.1, or Nimbus, represents about a third of new US Covid-19 cases. Dr. Leana Wen answers common questions about the new variant.

A newer COVID-19 variant may be causing a severe sore throat in some people who contract the infection. The variant, known as NB.1.8.1, has been nicknamed by some as "razor blade throat" due to ...

From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.